KO Cell Line - Mitophagy KO Cell Line - Mitophagy

Mitophagy is a selective process that removes damaged mitochondria to maintain cellular homeostasis. Dysregulation of mitophagy is closely associated with neurodegenerative diseases, cardiovascular disorders, cancer, and aging-related metabolic dysfunction.

Mitophagy knockout cell lines enable precise investigation of mitochondrial quality control and disease mechanisms. Below, explore EDITGENE’s mitophagy-related KO cell models and their key research applications.

Mitophagy is a specialized form of autophagy that selectively eliminates damaged or unnecessary mitochondria. This process is essential for maintaining mitochondrial integrity, energy balance, and cellular health.

Mitophagy is mainly regulated through two major pathways:

· PINK1/Parkin-dependent pathway
Upon mitochondrial damage, PINK1 accumulates on the outer mitochondrial membrane and recruits the E3 ligase Parkin, triggering ubiquitination of mitochondrial proteins and recruitment of autophagy adaptors such as p62, NBR1, and OPTN, leading to autophagosome formation.

· Receptor-mediated pathways (PINK1/Parkin-independent)
Proteins such as BNIP3 and BNIP3L/NIX, containing LC3-interacting regions (LIRs), directly recruit autophagy machinery under conditions like hypoxia, enabling ubiquitin-independent mitophagy.

Mitophagy can be triggered by multiple conditions, including mitochondrial damage (loss of membrane potential, ROS accumulation), nutrient deprivation (AMPK activation and mTOR inhibition), hypoxia, and cellular stress.

Given its central role in mitochondrial quality control, mitophagy is critical for understanding cell survival, stress adaptation, and disease progression.

Mitophagy

Li et al., Cell Death Dis, 2022

Mitophagy plays a key role in regulating energy homeostasis, oxidative stress response, and mitochondrial quality control, and is closely linked to multiple diseases, including cardiovascular diseases, neurodegeneration, cancer, and aging-related disorders.

Gene knockout cell models provide powerful tools to dissect mitophagy mechanisms and evaluate therapeutic strategies targeting mitochondrial dysfunction.

· Cancer & Hypoxia Models
Study hypoxia-induced mitophagy using models such as BNIP3/NIX double knockout (DKO) cells, and investigate how mitophagy regulates tumor cell survival, ferroptosis resistance, and metabolic adaptation.

· Cardiovascular Disease Models
Explore the role of mitophagy in ischemia/reperfusion injury, where it helps remove damaged mitochondria and reduce ROS accumulation, as well as its contribution to heart failure progression.

· Neurodegeneration & Aging Models
Investigate how impaired mitophagy contributes to mitochondrial dysfunction, ROS accumulation, and age-related cellular decline, providing insights into neurodegenerative diseases and aging.

· Stress & Metabolic Models
Analyze mitophagy under conditions such as nutrient deprivation, hypoxia, and toxin exposure, and study how pathways like AMPK–ULK1 signaling regulate mitochondrial turnover and cellular metabolism.

Explore the Mitophagy-Related Knockout Cell Line Collection from EDITGENE, featuring validated models targeting key regulators of mitochondrial quality control and autophagy pathways.

EDITGENE provides high-quality Mitophagy Knockout Cell Lines for studying mitochondrial dynamics, stress responses, and disease mechanisms, including models such as BNIP3/NIX DKO and PINK1/Parkin pathway genes. Both in-stock and custom gene knockout cell lines are available to support diverse mitophagy, aging, and disease research needs.

Displaying Records 1 To 15 Of 213 Records
Contact Us
*
*
*
*
How did you hear about us：
✖ service online